4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-040615
Director sold 2,075 shares at $19.34 ($40,132)
From the SEC's structured data for this filing
Trades in this filing
Chrousos Phaedra · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-14 | Sale : show line 1 in the form | −2,075 | $19.34 | $40,132 | 12,925 | D |
| Open-market sales · 2,075 sh · avg $19.34 · $40,132 | ||||||
Loading xslF345X03/doc4.xml…